Cabaletta Bio Inc [CABA] stock is trading at $2.06, up 10.16%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CABA shares have gain 17.71% over the last week, with a monthly amount glided 64.80%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cabaletta Bio Inc [NASDAQ: CABA] stock has seen the most recent analyst activity on December 20, 2024, when Evercore ISI downgraded its rating to a In-line and also revised its price target to $6 from $15. Previously, Wells Fargo downgraded its rating to Equal Weight on December 19, 2024, and dropped its price target to $6. On October 10, 2024, UBS initiated with a Buy rating and assigned a price target of $10 on the stock. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $36 on February 05, 2024. William Blair initiated its recommendation with a Outperform and recommended $38 as its price target on November 29, 2023. Cantor Fitzgerald started tracking with a Overweight rating for this stock on October 24, 2023, and assigned it a price target of $40. In a note dated October 19, 2023, Stifel initiated an Buy rating and provided a target price of $31 on this stock.
Cabaletta Bio Inc [CABA] stock has fluctuated between $0.99 and $13.50 over the past year. Currently, Wall Street analysts expect the stock to reach $16.33 within the next 12 months. Cabaletta Bio Inc [NASDAQ: CABA] shares were valued at $2.06 at the most recent close of the market. An investor can expect a potential return of 692.72% based on the average CABA price forecast.
Analyzing the CABA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.77, Equity is -0.78 and Total Capital is -1.02. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.24.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.9100 points at the first support level, and at 1.7700 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.1400, and for the 2nd resistance point, it is at 2.2300.
Ratios To Look Out For
For context, Cabaletta Bio Inc’s Current Ratio is 3.96. Further, the Quick Ratio stands at 3.96, while the Cash Ratio is 3.88.
